Raju Prasad

Insider Reports History

Entity
Individual
Location
Crispr Therapeutics, Inc., 105 W First Street, Boston, MA
Signature
Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raju Prasad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 16.8K $691K $41.23 Mar 21, 2025 Direct
CRISPR Therapeutics AG Chief Financial Officer Stock Option (Right to Buy) 36.7K Mar 14, 2025 Direct
CRISPR Therapeutics AG Chief Financial Officer Restricted Stock Units 18.8K Mar 20, 2025 Direct

Insider Reports Filed by Raju Prasad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Mar 20, 2025 3 -$90.6K 4 Mar 24, 2025 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2025 5 -$157K 4 Mar 18, 2025 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 16, 2024 2 $0 4 Oct 18, 2024 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 20, 2024 2 $0 4 Mar 22, 2024 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2024 3 -$256K 4 Mar 18, 2024 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 13, 2023 1 $0 4 Oct 17, 2023 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2023 2 $0 4 Mar 14, 2023 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2023 0 $0 3 Mar 14, 2023 Chief Financial Officer